US20130123808A1 - Heart-Shaped PFO Closure Device - Google Patents

Heart-Shaped PFO Closure Device Download PDF

Info

Publication number
US20130123808A1
US20130123808A1 US13/734,516 US201313734516A US2013123808A1 US 20130123808 A1 US20130123808 A1 US 20130123808A1 US 201313734516 A US201313734516 A US 201313734516A US 2013123808 A1 US2013123808 A1 US 2013123808A1
Authority
US
United States
Prior art keywords
clip
defect
bioresorbable
closure
pfo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/734,516
Inventor
Andrzej J. CHANDUSZKO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WL Gore and Associates Inc
Original Assignee
WL Gore and Associates Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WL Gore and Associates Inc filed Critical WL Gore and Associates Inc
Priority to US13/734,516 priority Critical patent/US20130123808A1/en
Publication of US20130123808A1 publication Critical patent/US20130123808A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/08Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound
    • A61B17/083Clips, e.g. resilient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00592Elastic or resilient implements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00606Implements H-shaped in cross-section, i.e. with occluders on both sides of the opening
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00867Material properties shape memory effect

Definitions

  • the present invention relates to devices and methods that are used to close defects, and particularly for closing a patent foramen ovale (PFO).
  • PFO patent foramen ovale
  • a PFO is a persistent, one-way, usually flap-like opening in the wall between the right atrium 10 and left atrium 12 of the heart. Because left atrial pressure is normally higher than right atrial pressure, the flap formed by septum primum 14 and septum secundum 16 usually stays closed. Under certain conditions, however, right atrial pressure can exceed left atrial pressure, which creates the possibility that blood could pass from the right atrium to the left atrium through a PFO tunnel 18 and allow blood clots to enter the systemic circulation. It would be desirable to avoid this situation.
  • Embodiments of the present invention provide a device for closing septal defects, such as a patent foramen ovale (PFO).
  • the device has substantially circular proximal and distal configurations connected with a center joint.
  • the center joint has a generally square configuration.
  • the shape of the center joint provides for centering of the device in the defect.
  • the device can be made from wire, such as nitinol wire. Pieces of wire can be connected with tubes, welds, or other joining techniques.
  • the device can be retrieved after deployment and repositioned if needed. Either the distal (left atrial) clip, proximal (right atrial) clip, or both can be covered with a tissue scaffold to help the defect seal and to encourage tissue ingrowth.
  • Embodiments of the closure device can have one or more of the following advantages: an atraumatic shape, good embolization resistance, an ability to conform to the anatomy (instead of the anatomy conforming to the device, especially in the defect tunnel), repositionable or/and removable during delivery, and a small profile after deployment.
  • Other benefits include small diameter delivery sheath, ease of manufacturing, cost effectiveness, and overall simplicity.
  • FIG. 1 is a cross-sectional side view showing a patent foreman ovale (PFO).
  • FIGS. 2A and 2B are front elevational and top plan views of a device according to the present invention.
  • FIGS. 3A and 3B are right side elevational views of the device as made and as positioned in a PFO, respectively.
  • FIG. 4 is a prospective view and FIGS. 5 and 6 are front and rear elevational views showing the device of FIG. 2A as positioned in a PFO.
  • FIGS. 7 and 8 are views of the device in an elongated form and shown within a catheter for delivery, and FIG. 7A is a perspective view of an alternative embodiment to FIG. 7 .
  • FIGS. 9 and 9A are a perspective view of the device according to another embodiment of the present invention, and an enlarged detailed view of a portion of a that device, respectively.
  • FIG. 9B is a perspective view of an alternative embodiment to that in FIG. 9 .
  • FIG. 10 is a front elevational view of a device according to get another embodiment of the present invention.
  • FIGS. 10A-10C are elevational views of alternative configurations for a center joint in the device of FIG. 10 .
  • FIGS. 11A-11F are fragmentary front elevational views showing alternative loop designs.
  • Embodiments of the devices described here are intended to clip together tissue flaps, and particularly to clip together septum primum and septum secundum to minimize the flow of blood from the right atrium to the left atrium, thereby helping to reduce the risk of stroke.
  • the devices apply a compressive force between septum primum and septum secundum to bring septum primum and septum secundum together to provide a closing effect.
  • the applied compressive force draws the more flexible septum primum toward septum secundum, thereby closing the PFO without significantly distorting the septum.
  • the clip can provide mechanical closure at points of contact along the PFO such that the largest remaining opening is reduced to a size deemed small enough to block stroke-inducing embolic particles from crossing through the PFO tunnel: In other embodiments, the clip provides substantially complete closure along the entire PFO length. Because the clips do not distort the defect in preferred embodiments, the overlapping layers of septal tissues may themselves be used to close the defect as they are compressed by the clip.
  • a closure device 20 has a distal loop 22 , a proximal loop 24 , and a center joint 26 connecting loops 22 and 24 .
  • the loops are each generally “heart-shaped” and have two lobes that come together.
  • FIG. 2A there are several points in the device where wires or portions of a wire meet. At these points, the wires can be welded and/or clamped with a collar 28 , 30 , 32 , and 34 . Collars 28 and 30 are formed at outer vertices of loops 24 and 22 , respectively; collars 32 and 34 are provided where the lobes of the loops come together at center joint 26 .
  • Center joint 26 has generally four sides and is preferably generally rectangular in shape in that it has basically four sides with two sets of parallel sides coming together at roughly right angles. While “rectangular” strictly might imply sharp corners, it should be understood that the corners here can be rounded or have other configurations as are present at the location of collars 32 and 34 as shown in FIG. 2A .
  • the sides can be straight, but can also have some bends or curves while the overall look is still generally rectangular. More preferably, the center joint is generally square. Other shapes could be used, including circular, polygonal, or some combination of straight and curved segments.
  • the two wire paths from collar 32 to collar 34 preferably have about the same length, thus making it easier to load the device in a catheter or sheath.
  • FIG. 2B shows a top plan view with loops 22 and 24 that are in substantially parallel configuration and parallel to center joint 26 from this view.
  • the device could have this configuration, although it could be formed such that, in its non-deployed configuration, loops 22 and 24 are curved in the vertical plane such that the ends, shown at collars 28 and 30 , bend to an opposite side of a center line 31 that runs through center joint 26 .
  • loop 24 could start one side of center line 31 and have its outer vertex at collar 28 on the other side of line 31 , and similarly for loop 22 .
  • This overlapping effect can help provide good compressive force, especially for materials with less recovery. For materials with very high recovery, such as nitinol, such a configuration might not be desirable.
  • device 20 is shown in a non-deployed configuration ( FIG. 3A ), and as deployed (FIGS. 3 B and 4 - 6 ).
  • loops 22 and 24 each have a respective upper portion or top lobe in contact with septum secundum 16 and a lower portion or lower lobe in contact with septum primum 14 .
  • the loops generally define a plane that is generally parallel to each of septum primum and septum secundum. This configuration helps distribute compressive forces across the applicable septum and makes the pressure less traumatic.
  • center joint 26 is partially on the right atrial side, partially on the left atrial side, and partially within PFO tunnel 18 ( FIG. 1 ) where the flaps of septum secundum 16 ( FIG. 4 ) and septum primum 14 ( FIG. 4 ) overlap.
  • the center joint could be completely within the overlapping portions of septum primum and septum secundum.
  • the loops and center joint are formed with appropriate dimensions and materials, and in such a configuration, such that when deployed, the loops provide a compressive force that holds together septum primum 14 and septum secundum 16 .
  • the device can be deployed with a delivery sheath in the generally conventional manner.
  • FIGS. 7 and 8 show device 20 in an elongated form for delivery purposes.
  • Device 20 can be provided with a low profile to fit within a sheath 40 and have an end, such as at collar 28 , in a contact with a connector 42 at the end of a wire 44 that is used by an operator to push the device or hold the device as sheath 40 is retracted, i.e., the connection allows relative movement between device 20 and sheath 40 .
  • device 20 is deployed by providing sheath 40 within the left atrium and withdrawing sheath 40 while wire 44 and connector 42 hold device 20 in place.
  • loop 22 opens and assumes the shape shown in FIG. 6 .
  • Sheath 40 is further drawn back within the PFO tunnel to release center joint 26 , and then is further drawn back into the right atrium to allow loop 24 to open in the right atrium.
  • Connector 42 can stay in contact until the device is at a desired positioning of device 20 . If the operator is not satisfied with the positioning of device 20 , the connector can be used to pull the device or hold the device while the sheath is pushed forward to draw the device back into the sheath to be removed or redeployed.
  • FIG. 7A shows an embodiment that is similar to that of FIG. 7 , except that rather than a collar 28 , there is a curved portion 28 ′ in the wire used to form loop 24 . While shown as a more gradual bend, it could have a sharper bend, such as a hairpin turn. A curved portion without a collar could be used on the other side where collar 30 is, and in other embodiments where a collar is shown.
  • FIGS. 9 and 9A show another embodiment of the present invention.
  • device 90 has a loop 92 for use in the left atrium and loop 94 for use in the right atrium.
  • a tissue scaffold 96 is shown within loop 92 for deployment in the left atrium, and a scaffold is shown connected to loop 94 to be released in the right atrium.
  • FIG. 9A where two portions of wire come together in loop 92 , a weld 99 is formed to hold the wires together.
  • tissue scaffold 96 is shown attached to the wire over most of its distance up to where the wires come together. This device would be delivered in a manner similar to that shown in FIGS. 7 and 8 above.
  • FIG. 9B shows a variation of FIG. 9 in which the weld 99 between two wires is replaced with a curved wire 99 ′ without the weld.
  • a device 100 has two heart shaped loops 102 and 104 , with a center joint 106 between them.
  • the center joint has contact points 114 , 116 for each of the loops at adjacent corners rather than being at diagonally opposite corners as shown in device 20 in FIG. 2A .
  • This configuration can improve rotational stability compared to the diagonal configuration (i.e., the device is less likely to rotate within the PFO tunnel).
  • Center joint 106 has three similar sides 108 a, 108 b, and 108 c forming a generally block-U shape. Rather than another similar side, however, a connector 110 is provided that allows for some flexing motion in the direction indicated by arrow 112 , and that approximately equalizes the length of the two paths between contact points 114 and 116 . These equal paths make it easier to load the device into a sheath or catheter.
  • connection 110 is shown in FIGS. 10A , 10 B, and 10 C. These figures show various alternative configurations of wires that form loops and angles that allow some ability for sides 108 a, 108 b, 108 c, and 110 to pivot with respect to one or more of the other sides, and that equalize the two path lengths of wires between contact points 114 and 116 , thereby helping to make it easier to load the device into a sheath or catheter when it is elongated to a smaller profile.
  • FIGS. 11A-11E show alternative loop configurations. These include a generally circular configuration with two collars ( FIG. 11A ), a generally rectangular configuration with two collars ( FIG. 11B ), a heart-shape with straight lines converging on a vertex to provide a more triangular shape ( FIG. 11C ) than other configuration, such as that shown in FIG. 2A , a FIG. 8 ( FIG. 11D ), a generally circular configuration with one collars ( FIG. 11E ), and a generally rectangular configuration with one collar ( FIG. 11F ).
  • Other shapes could be used, although it is preferred (but not required) that the wires do not cross in a way that would create rubbing contact.
  • a single wire could be used with several double-backs, or multiple wires could be used and welded or crimped together with a collar at desired locations.
  • the clips can be formed of metal or nonmetallic materials, including bioresorbable polymers, spring steel, shape memory materials (e.g., nitinol), bioresorbable shape memory polymers, or combinations of the foregoing materials.
  • Shape memory materials are useful for this application. These materials allow the clips to resume and maintain their intended shape following deployment in vivo.
  • a clip may take advantage of the thermal shape memory properties of a shape memory material, the superelastic properties of a shape memory material, or some combination of the two.
  • the clips are cut into their desired shapes from sheets of material, such as from bioresorbable shape memory polymers.
  • the first and second loops are preferably made from a material or are configured to apply a compressive force to the overlapping layers of septal tissue.
  • the movement of the at least two loops may be limited by the edges of the PFO tunnel (which is usually between 1 mm and 20 mm wide), thereby ensuring the clip device remains horizontally centered across the defect and consistently applies compressive force to the septal tissues at the locations necessary to effect closure of the defect. Accurate and consistent application of localized force can allow the use of a smaller closure device.
  • the closure loops of a clip may take various forms depending, in part, on the distribution of force desired to effect closure of a given defect.
  • the term “defect” is applied to any anatomical configuration requiring treatment.
  • the defect can be a PFO which may allow, or allows, blood to flow from the right atrium to the left atrium.
  • the shape of each closure member determines the location(s) at which the compressive force is applied to the overlapping layers of septal tissue.
  • tissue scaffold on one or both closure members and/or the center joint.
  • the tissue scaffold promotes encapsulation and endothelialization, thereby further encouraging anatomical closure of septum primum and septum secundum.
  • a tissue scaffold can be formed of any flexible, biocompatible material capable of promoting tissue ingrowth, including but not limited to polyester fabrics, Teflon-based materials, such as ePTFE, polyurethanes, metallic materials, polyvinyl alcohol (PVA), extracellular matrix (ECM) or other bioengineered material, synthetic bioabsorbable polymeric scaffolds, other natural materials (e.g., collagen), or combinations of these materials.
  • a tissue scaffold may be formed of a thin metallic film or foil. The scaffold may be attached to one or both sides of the device.
  • a tissue scaffold or the frame may contain drugs or biological agents to improve the defect healing process and/or to prevent clotting.
  • the center joint serves a horizontal centering function.
  • the connecting members may be designed to fit within the PFO tunnel such that there is little (or no) horizontal movement once the device is deployed. Horizontal centering is desirable because the dynamic conditions in the heart may tend to move the device.
  • Other configurations, including bent or slightly bent wires, to position the connecting members within the PFO tunnel can be used.
  • the compressive force applied by the closure members of any of the various embodiments described herein can be adjusted in a variety of ways.
  • the thickness of a strand or wire can be increased or decreased to adjust the compressive force.
  • a thicker strand or wire will provide higher compressive force.
  • various closure member configurations may be chosen to increase the compressive force. Generally, bends with smaller angles will provide more compressive force.
  • Different parts of the device can be treated in a different manner to alter stiffness and recovery, as described in applicable Ser. No. 10/702,717 filed Nov. 6, 2003, which is incorporated herein by reference.
  • the devices described here have some general similarities to some devices in application Ser. No. 10/396,253, filed Mar. 25, 2003, published as 2003/0225421, which is incorporated herein be reference.

Abstract

Patent foramen ovale (PFO) closure clip include two closure members, which may be heart shaped, joined by at least two spaced central connecting members. Each of the at least two spaced central connecting members is attached to each closure member at a location on the periphery of the closure member. The connecting member may be generally square shaped or include other shapes. The clips of the present invention may be formed of various materials, including metals, nonmetallic materials, bioresorbable polymers, spring steel, shape memory materials, bioresorbable shape memory polymers, or combinations thereof. The clips can take various forms depending, in part, upon the distribution of force required to close a given PFO. At least one of the closure members can include a tissue scaffold.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation application of U.S. application Ser. No. 11/111,675 filed Apr. 21, 2005, now pending; which claims the benefit under 35 USC §119(e) to U.S. Application Ser. No. 60/565,285 filed Apr. 26, 2004, now expired. The disclosure of each of the prior applications is considered part of and is incorporated by reference in the disclosure of this application.
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • The present invention relates to devices and methods that are used to close defects, and particularly for closing a patent foramen ovale (PFO).
  • 2. Background of the Invention
  • A PFO, illustrated in FIG. 1, is a persistent, one-way, usually flap-like opening in the wall between the right atrium 10 and left atrium 12 of the heart. Because left atrial pressure is normally higher than right atrial pressure, the flap formed by septum primum 14 and septum secundum 16 usually stays closed. Under certain conditions, however, right atrial pressure can exceed left atrial pressure, which creates the possibility that blood could pass from the right atrium to the left atrium through a PFO tunnel 18 and allow blood clots to enter the systemic circulation. It would be desirable to avoid this situation.
  • SUMMARY OF THE INVENTION
  • Embodiments of the present invention provide a device for closing septal defects, such as a patent foramen ovale (PFO). The device has substantially circular proximal and distal configurations connected with a center joint. In most embodiments, the center joint has a generally square configuration. The shape of the center joint provides for centering of the device in the defect. The device can be made from wire, such as nitinol wire. Pieces of wire can be connected with tubes, welds, or other joining techniques. The device can be retrieved after deployment and repositioned if needed. Either the distal (left atrial) clip, proximal (right atrial) clip, or both can be covered with a tissue scaffold to help the defect seal and to encourage tissue ingrowth.
  • Embodiments of the closure device can have one or more of the following advantages: an atraumatic shape, good embolization resistance, an ability to conform to the anatomy (instead of the anatomy conforming to the device, especially in the defect tunnel), repositionable or/and removable during delivery, and a small profile after deployment. Other benefits include small diameter delivery sheath, ease of manufacturing, cost effectiveness, and overall simplicity. Other features and advantages will become apparent from the following detailed description and drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a cross-sectional side view showing a patent foreman ovale (PFO).
  • FIGS. 2A and 2B are front elevational and top plan views of a device according to the present invention.
  • FIGS. 3A and 3B are right side elevational views of the device as made and as positioned in a PFO, respectively.
  • FIG. 4 is a prospective view and FIGS. 5 and 6 are front and rear elevational views showing the device of FIG. 2A as positioned in a PFO.
  • FIGS. 7 and 8 are views of the device in an elongated form and shown within a catheter for delivery, and FIG. 7A is a perspective view of an alternative embodiment to FIG. 7.
  • FIGS. 9 and 9A are a perspective view of the device according to another embodiment of the present invention, and an enlarged detailed view of a portion of a that device, respectively. FIG. 9B is a perspective view of an alternative embodiment to that in FIG. 9.
  • FIG. 10 is a front elevational view of a device according to get another embodiment of the present invention.
  • FIGS. 10A-10C are elevational views of alternative configurations for a center joint in the device of FIG. 10.
  • FIGS. 11A-11F are fragmentary front elevational views showing alternative loop designs.
  • DETAILED DESCRIPTION OF THE INVENTION
  • Embodiments of the devices described here are intended to clip together tissue flaps, and particularly to clip together septum primum and septum secundum to minimize the flow of blood from the right atrium to the left atrium, thereby helping to reduce the risk of stroke. To accomplish this, the devices apply a compressive force between septum primum and septum secundum to bring septum primum and septum secundum together to provide a closing effect. In at least some embodiments, the applied compressive force draws the more flexible septum primum toward septum secundum, thereby closing the PFO without significantly distorting the septum. The clip can provide mechanical closure at points of contact along the PFO such that the largest remaining opening is reduced to a size deemed small enough to block stroke-inducing embolic particles from crossing through the PFO tunnel: In other embodiments, the clip provides substantially complete closure along the entire PFO length. Because the clips do not distort the defect in preferred embodiments, the overlapping layers of septal tissues may themselves be used to close the defect as they are compressed by the clip.
  • Referring to FIGS. 2A and 2B, a closure device 20 has a distal loop 22, a proximal loop 24, and a center joint 26 connecting loops 22 and 24. In this embodiment, the loops are each generally “heart-shaped” and have two lobes that come together. As shown in FIG. 2A, there are several points in the device where wires or portions of a wire meet. At these points, the wires can be welded and/or clamped with a collar 28, 30, 32, and 34. Collars 28 and 30 are formed at outer vertices of loops 24 and 22, respectively; collars 32 and 34 are provided where the lobes of the loops come together at center joint 26.
  • Center joint 26 has generally four sides and is preferably generally rectangular in shape in that it has basically four sides with two sets of parallel sides coming together at roughly right angles. While “rectangular” strictly might imply sharp corners, it should be understood that the corners here can be rounded or have other configurations as are present at the location of collars 32 and 34 as shown in FIG. 2A. The sides can be straight, but can also have some bends or curves while the overall look is still generally rectangular. More preferably, the center joint is generally square. Other shapes could be used, including circular, polygonal, or some combination of straight and curved segments. The two wire paths from collar 32 to collar 34 preferably have about the same length, thus making it easier to load the device in a catheter or sheath.
  • FIG. 2B shows a top plan view with loops 22 and 24 that are in substantially parallel configuration and parallel to center joint 26 from this view. The device could have this configuration, although it could be formed such that, in its non-deployed configuration, loops 22 and 24 are curved in the vertical plane such that the ends, shown at collars 28 and 30, bend to an opposite side of a center line 31 that runs through center joint 26. In other words, as shown by the arrows in FIG. 2B, loop 24 could start one side of center line 31 and have its outer vertex at collar 28 on the other side of line 31, and similarly for loop 22. This overlapping effect can help provide good compressive force, especially for materials with less recovery. For materials with very high recovery, such as nitinol, such a configuration might not be desirable.
  • Referring to FIGS. 3A, 3B and 4-6, device 20 is shown in a non-deployed configuration (FIG. 3A), and as deployed (FIGS. 3B and 4-6). As indicated in these views, loops 22 and 24 each have a respective upper portion or top lobe in contact with septum secundum 16 and a lower portion or lower lobe in contact with septum primum 14. The loops generally define a plane that is generally parallel to each of septum primum and septum secundum. This configuration helps distribute compressive forces across the applicable septum and makes the pressure less traumatic.
  • As shown particularly in FIGS. 5 and 6, which represent views from the right atrium (FIG. 5) and left atrium (FIG. 6), center joint 26 is partially on the right atrial side, partially on the left atrial side, and partially within PFO tunnel 18 (FIG. 1) where the flaps of septum secundum 16 (FIG. 4) and septum primum 14 (FIG. 4) overlap. The center joint could be completely within the overlapping portions of septum primum and septum secundum.
  • The loops and center joint are formed with appropriate dimensions and materials, and in such a configuration, such that when deployed, the loops provide a compressive force that holds together septum primum 14 and septum secundum 16.
  • Referring to FIGS. 7 and 8, the device can be deployed with a delivery sheath in the generally conventional manner. FIGS. 7 and 8 show device 20 in an elongated form for delivery purposes. Device 20 can be provided with a low profile to fit within a sheath 40 and have an end, such as at collar 28, in a contact with a connector 42 at the end of a wire 44 that is used by an operator to push the device or hold the device as sheath 40 is retracted, i.e., the connection allows relative movement between device 20 and sheath 40. Typically, device 20 is deployed by providing sheath 40 within the left atrium and withdrawing sheath 40 while wire 44 and connector 42 hold device 20 in place. As sheath 40 is withdrawn, loop 22 opens and assumes the shape shown in FIG. 6. Sheath 40 is further drawn back within the PFO tunnel to release center joint 26, and then is further drawn back into the right atrium to allow loop 24 to open in the right atrium. Connector 42 can stay in contact until the device is at a desired positioning of device 20. If the operator is not satisfied with the positioning of device 20, the connector can be used to pull the device or hold the device while the sheath is pushed forward to draw the device back into the sheath to be removed or redeployed.
  • FIG. 7A shows an embodiment that is similar to that of FIG. 7, except that rather than a collar 28, there is a curved portion 28′ in the wire used to form loop 24. While shown as a more gradual bend, it could have a sharper bend, such as a hairpin turn. A curved portion without a collar could be used on the other side where collar 30 is, and in other embodiments where a collar is shown.
  • FIGS. 9 and 9A show another embodiment of the present invention. In this embodiment, device 90 has a loop 92 for use in the left atrium and loop 94 for use in the right atrium. A tissue scaffold 96 is shown within loop 92 for deployment in the left atrium, and a scaffold is shown connected to loop 94 to be released in the right atrium. As shown in FIG. 9A, where two portions of wire come together in loop 92, a weld 99 is formed to hold the wires together. As also indicated here, tissue scaffold 96 is shown attached to the wire over most of its distance up to where the wires come together. This device would be delivered in a manner similar to that shown in FIGS. 7 and 8 above. FIG. 9B shows a variation of FIG. 9 in which the weld 99 between two wires is replaced with a curved wire 99′ without the weld.
  • Referring to FIG. 10, in another embodiment of the present invention, a device 100 has two heart shaped loops 102 and 104, with a center joint 106 between them. In this case, the center joint has contact points 114, 116 for each of the loops at adjacent corners rather than being at diagonally opposite corners as shown in device 20 in FIG. 2A. This configuration can improve rotational stability compared to the diagonal configuration (i.e., the device is less likely to rotate within the PFO tunnel).
  • Center joint 106 has three similar sides 108 a, 108 b, and 108 c forming a generally block-U shape. Rather than another similar side, however, a connector 110 is provided that allows for some flexing motion in the direction indicated by arrow 112, and that approximately equalizes the length of the two paths between contact points 114 and 116. These equal paths make it easier to load the device into a sheath or catheter.
  • Alternative connections to connection 110 are shown in FIGS. 10A, 10B, and 10C. These figures show various alternative configurations of wires that form loops and angles that allow some ability for sides 108 a, 108 b, 108 c, and 110 to pivot with respect to one or more of the other sides, and that equalize the two path lengths of wires between contact points 114 and 116, thereby helping to make it easier to load the device into a sheath or catheter when it is elongated to a smaller profile.
  • FIGS. 11A-11E show alternative loop configurations. These include a generally circular configuration with two collars (FIG. 11A), a generally rectangular configuration with two collars (FIG. 11B), a heart-shape with straight lines converging on a vertex to provide a more triangular shape (FIG. 11C) than other configuration, such as that shown in FIG. 2A, a FIG. 8 (FIG. 11D), a generally circular configuration with one collars (FIG. 11E), and a generally rectangular configuration with one collar (FIG. 11F). Other shapes could be used, although it is preferred (but not required) that the wires do not cross in a way that would create rubbing contact.
  • In most of these embodiments, a single wire could be used with several double-backs, or multiple wires could be used and welded or crimped together with a collar at desired locations. The clips can be formed of metal or nonmetallic materials, including bioresorbable polymers, spring steel, shape memory materials (e.g., nitinol), bioresorbable shape memory polymers, or combinations of the foregoing materials.
  • Shape memory materials are useful for this application. These materials allow the clips to resume and maintain their intended shape following deployment in vivo. A clip may take advantage of the thermal shape memory properties of a shape memory material, the superelastic properties of a shape memory material, or some combination of the two. In other particular embodiments, the clips are cut into their desired shapes from sheets of material, such as from bioresorbable shape memory polymers.
  • The first and second loops are preferably made from a material or are configured to apply a compressive force to the overlapping layers of septal tissue. The movement of the at least two loops may be limited by the edges of the PFO tunnel (which is usually between 1 mm and 20 mm wide), thereby ensuring the clip device remains horizontally centered across the defect and consistently applies compressive force to the septal tissues at the locations necessary to effect closure of the defect. Accurate and consistent application of localized force can allow the use of a smaller closure device.
  • The closure loops of a clip may take various forms depending, in part, on the distribution of force desired to effect closure of a given defect. In this application, the term “defect” is applied to any anatomical configuration requiring treatment. In particular, the defect can be a PFO which may allow, or allows, blood to flow from the right atrium to the left atrium. The shape of each closure member determines the location(s) at which the compressive force is applied to the overlapping layers of septal tissue.
  • Any of the embodiments of the present invention can include a tissue scaffold on one or both closure members and/or the center joint. The tissue scaffold promotes encapsulation and endothelialization, thereby further encouraging anatomical closure of septum primum and septum secundum. A tissue scaffold can be formed of any flexible, biocompatible material capable of promoting tissue ingrowth, including but not limited to polyester fabrics, Teflon-based materials, such as ePTFE, polyurethanes, metallic materials, polyvinyl alcohol (PVA), extracellular matrix (ECM) or other bioengineered material, synthetic bioabsorbable polymeric scaffolds, other natural materials (e.g., collagen), or combinations of these materials. Also, a tissue scaffold may be formed of a thin metallic film or foil. The scaffold may be attached to one or both sides of the device. A tissue scaffold or the frame may contain drugs or biological agents to improve the defect healing process and/or to prevent clotting.
  • The center joint serves a horizontal centering function. Specifically, the connecting members may be designed to fit within the PFO tunnel such that there is little (or no) horizontal movement once the device is deployed. Horizontal centering is desirable because the dynamic conditions in the heart may tend to move the device. Other configurations, including bent or slightly bent wires, to position the connecting members within the PFO tunnel can be used.
  • The compressive force applied by the closure members of any of the various embodiments described herein can be adjusted in a variety of ways. For example, the thickness of a strand or wire can be increased or decreased to adjust the compressive force. In general (and with other design considerations similar), a thicker strand or wire will provide higher compressive force. Additionally, various closure member configurations may be chosen to increase the compressive force. Generally, bends with smaller angles will provide more compressive force. Different parts of the device can be treated in a different manner to alter stiffness and recovery, as described in applicable Ser. No. 10/702,717 filed Nov. 6, 2003, which is incorporated herein by reference.
  • In some general respects, such as the ability to use one wire, the devices described here have some general similarities to some devices in application Ser. No. 10/396,253, filed Mar. 25, 2003, published as 2003/0225421, which is incorporated herein be reference.
  • Having described embodiments of the present invention, it should be apparent that the invention is capable of other and different embodiments and may be modified in various respects, all without departing from the scope of the invention as defined by the appended claims. Accordingly, the foregoing drawings and description are to be regarded as illustrative in nature and not in a restrictive or limiting sense.

Claims (3)

What is claimed is:
1. A clip for closing a septal defect having a length and dividing a left atrium and a right atrium in a mammalian heart, the clip comprising:
first and second bioresorbable closure members configured, when deployed from a compressed to expanded form into a septal defect to place the first member in the left atrium and the second into the right atrium, as opposing loops in planes parallel to one another and to the length of the defect, wherein the closure members cooperate to apply a compressive force to the defect on deployment;
a bioresorbable tissue scaffold disposed on each closure member; and
a center joint connecting the first and second opposed closure members, the center joint being squared for centering of the clip within the septal defect and perpendicular to the closure members when deployed;
wherein centering and deployment of the clip within the defect brings the tissue scaffold into contact with the defect.
2. The clip of claim 1, wherein the bioresorbable material present in the clip is selected from the group consisting of metals, nonmetallic materials, bioresorbable polymers, spring steel, shape memory materials, bioresorbable shape memory polymers, and combinations thereof.
3. A delivery assembly comprising a catheter and the clip according to claim 1, wherein the catheter contains the device in an elongated form.
US13/734,516 2004-04-26 2013-01-04 Heart-Shaped PFO Closure Device Abandoned US20130123808A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/734,516 US20130123808A1 (en) 2004-04-26 2013-01-04 Heart-Shaped PFO Closure Device

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56528504P 2004-04-26 2004-04-26
US11/111,675 US8361110B2 (en) 2004-04-26 2005-04-21 Heart-shaped PFO closure device
US13/734,516 US20130123808A1 (en) 2004-04-26 2013-01-04 Heart-Shaped PFO Closure Device

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/111,675 Continuation US8361110B2 (en) 2004-04-26 2005-04-21 Heart-shaped PFO closure device

Publications (1)

Publication Number Publication Date
US20130123808A1 true US20130123808A1 (en) 2013-05-16

Family

ID=35426406

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/111,675 Active 2027-01-15 US8361110B2 (en) 2004-04-26 2005-04-21 Heart-shaped PFO closure device
US13/734,516 Abandoned US20130123808A1 (en) 2004-04-26 2013-01-04 Heart-Shaped PFO Closure Device

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US11/111,675 Active 2027-01-15 US8361110B2 (en) 2004-04-26 2005-04-21 Heart-shaped PFO closure device

Country Status (1)

Country Link
US (2) US8361110B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10426473B2 (en) * 2017-10-19 2019-10-01 Abbott Cardiovascular Systems Inc. System and method for plicating a heart valve
US11607207B2 (en) * 2016-05-16 2023-03-21 Boston Scientific Scimed, Inc. Devices and methods for reducing a dimension of openings in tissue

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060052821A1 (en) 2001-09-06 2006-03-09 Ovalis, Inc. Systems and methods for treating septal defects
US6702835B2 (en) 2001-09-07 2004-03-09 Core Medical, Inc. Needle apparatus for closing septal defects and methods for using such apparatus
US6776784B2 (en) 2001-09-06 2004-08-17 Core Medical, Inc. Clip apparatus for closing septal defects and methods of use
US8021359B2 (en) 2003-02-13 2011-09-20 Coaptus Medical Corporation Transseptal closure of a patent foramen ovale and other cardiac defects
US7972330B2 (en) 2003-03-27 2011-07-05 Terumo Kabushiki Kaisha Methods and apparatus for closing a layered tissue defect
JP4382087B2 (en) 2003-03-27 2009-12-09 テルモ株式会社 Method and apparatus for treatment of patent foramen ovale
US8021362B2 (en) 2003-03-27 2011-09-20 Terumo Kabushiki Kaisha Methods and apparatus for closing a layered tissue defect
US6939348B2 (en) 2003-03-27 2005-09-06 Cierra, Inc. Energy based devices and methods for treatment of patent foramen ovale
US7293562B2 (en) 2003-03-27 2007-11-13 Cierra, Inc. Energy based devices and methods for treatment of anatomic tissue defects
US7186251B2 (en) 2003-03-27 2007-03-06 Cierra, Inc. Energy based devices and methods for treatment of patent foramen ovale
US7165552B2 (en) 2003-03-27 2007-01-23 Cierra, Inc. Methods and apparatus for treatment of patent foramen ovale
CN1852688A (en) 2003-05-19 2006-10-25 斯托特药物集团公司 Tissue distention device and related methods for therapeutic intervention
ES2428967T3 (en) 2003-07-14 2013-11-12 W.L. Gore & Associates, Inc. Oval foramen tubular permeable closure device (FOP) with retention system
US8480706B2 (en) 2003-07-14 2013-07-09 W.L. Gore & Associates, Inc. Tubular patent foramen ovale (PFO) closure device with catch system
US9861346B2 (en) 2003-07-14 2018-01-09 W. L. Gore & Associates, Inc. Patent foramen ovale (PFO) closure device with linearly elongating petals
US20050267524A1 (en) 2004-04-09 2005-12-01 Nmt Medical, Inc. Split ends closure device
US7367975B2 (en) 2004-06-21 2008-05-06 Cierra, Inc. Energy based devices and methods for treatment of anatomic tissue defects
EP1869424A4 (en) 2005-04-11 2015-01-14 Terumo Corp Methods and apparatus to achieve a closure of a layered tissue defect
US8579936B2 (en) 2005-07-05 2013-11-12 ProMed, Inc. Centering of delivery devices with respect to a septal defect
US7846179B2 (en) 2005-09-01 2010-12-07 Ovalis, Inc. Suture-based systems and methods for treating septal defects
US20070123824A1 (en) * 2005-10-17 2007-05-31 Coaptus Medical Corporation Systems and methods for directing valves that control a vacuum applied to a patient
WO2007089277A1 (en) 2006-01-31 2007-08-09 Regents Of The University Of Minnesota Surgical support structure
US20070244494A1 (en) * 2006-04-18 2007-10-18 Downing Stephen W Methods and devices for treating atrial septal defects
US20070293808A1 (en) * 2006-04-27 2007-12-20 Williams Michael S Renal blood flow augmentation for congestive heart failure treatment
US8529597B2 (en) 2006-08-09 2013-09-10 Coherex Medical, Inc. Devices for reducing the size of an internal tissue opening
US20080039743A1 (en) * 2006-08-09 2008-02-14 Coherex Medical, Inc. Methods for determining characteristics of an internal tissue opening
US9220487B2 (en) 2006-08-09 2015-12-29 Coherex Medical, Inc. Devices for reducing the size of an internal tissue opening
US8894682B2 (en) * 2006-09-11 2014-11-25 Boston Scientific Scimed, Inc. PFO clip
US20080188892A1 (en) * 2007-02-01 2008-08-07 Cook Incorporated Vascular occlusion device
WO2008124603A1 (en) * 2007-04-05 2008-10-16 Nmt Medical, Inc. Septal closure device with centering mechanism
US9119607B2 (en) * 2008-03-07 2015-09-01 Gore Enterprise Holdings, Inc. Heart occlusion devices
US20130165967A1 (en) 2008-03-07 2013-06-27 W.L. Gore & Associates, Inc. Heart occlusion devices
US9138213B2 (en) * 2008-03-07 2015-09-22 W.L. Gore & Associates, Inc. Heart occlusion devices
US9307984B2 (en) 2008-04-16 2016-04-12 Children's Medical Center Corporation Tissue clip
US9402707B2 (en) 2008-07-22 2016-08-02 Neuravi Limited Clot capture systems and associated methods
US10702275B2 (en) * 2009-02-18 2020-07-07 St. Jude Medical Cardiology Division, Inc. Medical device with stiffener wire for occluding vascular defects
US9381006B2 (en) 2009-06-22 2016-07-05 W. L. Gore & Associates, Inc. Sealing device and delivery system
US9636094B2 (en) 2009-06-22 2017-05-02 W. L. Gore & Associates, Inc. Sealing device and delivery system
US20120029556A1 (en) 2009-06-22 2012-02-02 Masters Steven J Sealing device and delivery system
EP2504042A4 (en) * 2009-11-24 2017-11-22 Emory University Tissue support structure
WO2012052982A1 (en) 2010-10-22 2012-04-26 Neuravi Limited Clot engagement and removal system
US11259824B2 (en) 2011-03-09 2022-03-01 Neuravi Limited Clot retrieval device for removing occlusive clot from a blood vessel
EP2683309B1 (en) 2011-03-09 2021-04-21 Neuravi Limited A clot retrieval device for removing occlusive clot from a blood vessel
US9770232B2 (en) * 2011-08-12 2017-09-26 W. L. Gore & Associates, Inc. Heart occlusion devices
EP2572644A1 (en) 2011-09-22 2013-03-27 Occlutech Holding AG Medical implantable occlusion device
US9445797B2 (en) * 2012-09-13 2016-09-20 Medtronic, Inc. Percutaneous atrial and ventricular septal defect closure device
US10828019B2 (en) 2013-01-18 2020-11-10 W.L. Gore & Associates, Inc. Sealing device and delivery system
SI2967611T1 (en) 2013-03-14 2019-04-30 Neuravi Limited Devices for removal of acute blockages from blood vessels
US9433429B2 (en) 2013-03-14 2016-09-06 Neuravi Limited Clot retrieval devices
CN105208950A (en) 2013-03-14 2015-12-30 尼尔拉维有限公司 A clot retrieval device for removing occlusive clot from a blood vessel
US9808230B2 (en) 2014-06-06 2017-11-07 W. L. Gore & Associates, Inc. Sealing device and delivery system
US11253278B2 (en) 2014-11-26 2022-02-22 Neuravi Limited Clot retrieval system for removing occlusive clot from a blood vessel
EP3223723B1 (en) 2014-11-26 2020-01-08 Neuravi Limited A clot retrieval device for removing occlusive clot from a blood vessel
US10617435B2 (en) 2014-11-26 2020-04-14 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
US20160338706A1 (en) * 2015-05-20 2016-11-24 Edwards Lifesciences Corporation Atrial septal closure device for re-access
EP3854322B1 (en) 2016-09-06 2024-01-17 Neuravi Limited A clot retrieval device for removing occlusive clot from a blood vessel
US10993807B2 (en) 2017-11-16 2021-05-04 Medtronic Vascular, Inc. Systems and methods for percutaneously supporting and manipulating a septal wall
US10842498B2 (en) 2018-09-13 2020-11-24 Neuravi Limited Systems and methods of restoring perfusion to a vessel
US11406416B2 (en) 2018-10-02 2022-08-09 Neuravi Limited Joint assembly for vasculature obstruction capture device
US11712231B2 (en) 2019-10-29 2023-08-01 Neuravi Limited Proximal locking assembly design for dual stent mechanical thrombectomy device
US11517340B2 (en) 2019-12-03 2022-12-06 Neuravi Limited Stentriever devices for removing an occlusive clot from a vessel and methods thereof
US11730501B2 (en) 2020-04-17 2023-08-22 Neuravi Limited Floating clot retrieval device for removing clots from a blood vessel
US11871946B2 (en) 2020-04-17 2024-01-16 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
US11717308B2 (en) 2020-04-17 2023-08-08 Neuravi Limited Clot retrieval device for removing heterogeneous clots from a blood vessel
US11737771B2 (en) 2020-06-18 2023-08-29 Neuravi Limited Dual channel thrombectomy device
US11937836B2 (en) 2020-06-22 2024-03-26 Neuravi Limited Clot retrieval system with expandable clot engaging framework
US11395669B2 (en) 2020-06-23 2022-07-26 Neuravi Limited Clot retrieval device with flexible collapsible frame
US11439418B2 (en) 2020-06-23 2022-09-13 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
US11864781B2 (en) 2020-09-23 2024-01-09 Neuravi Limited Rotating frame thrombectomy device
US11937837B2 (en) 2020-12-29 2024-03-26 Neuravi Limited Fibrin rich / soft clot mechanical thrombectomy device

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5451235A (en) * 1991-11-05 1995-09-19 C.R. Bard, Inc. Occluder and method for repair of cardiac and vascular defects
US5733294A (en) * 1996-02-28 1998-03-31 B. Braun Medical, Inc. Self expanding cardiovascular occlusion device, method of using and method of making the same
US20030191495A1 (en) * 2001-12-19 2003-10-09 Nmt Medical, Inc. Septal occluder and associated methods
US20030225421A1 (en) * 2002-03-25 2003-12-04 Nmt Medical, Inc. Patent foramen ovale (PFO) closure clips

Family Cites Families (235)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3874388A (en) * 1973-02-12 1975-04-01 Ochsner Med Found Alton Shunt defect closure system
US3875648A (en) * 1973-04-04 1975-04-08 Dennison Mfg Co Fastener attachment apparatus and method
US3824631A (en) 1973-05-11 1974-07-23 Sampson Corp Bone joint fusion prosthesis
US3924631A (en) 1973-12-06 1975-12-09 Altair Inc Magnetic clamp
US4006747A (en) * 1975-04-23 1977-02-08 Ethicon, Inc. Surgical method
US4007743A (en) * 1975-10-20 1977-02-15 American Hospital Supply Corporation Opening mechanism for umbrella-like intravascular shunt defect closure device
CH598398A5 (en) * 1976-07-21 1978-04-28 Jura Elektroapparate Fab
US4425908A (en) * 1981-10-22 1984-01-17 Beth Israel Hospital Blood clot filter
JPS6171065A (en) 1984-09-13 1986-04-11 テルモ株式会社 Catheter introducer
US4696300A (en) 1985-04-11 1987-09-29 Dennison Manufacturing Company Fastener for joining materials
US4626245A (en) 1985-08-30 1986-12-02 Cordis Corporation Hemostatis valve comprising an elastomeric partition having opposed intersecting slits
US4710192A (en) 1985-12-30 1987-12-01 Liotta Domingo S Diaphragm and method for occlusion of the descending thoracic aorta
DE3774781D1 (en) * 1986-07-16 1992-01-09 Sumitomo Chemical Co RUBBER BLEND.
US5478353A (en) 1987-05-14 1995-12-26 Yoon; Inbae Suture tie device system and method for suturing anatomical tissue proximate an opening
US5250430A (en) 1987-06-29 1993-10-05 Massachusetts Institute Of Technology Polyhydroxyalkanoate polymerase
US5245023A (en) 1987-06-29 1993-09-14 Massachusetts Institute Of Technology Method for producing novel polyester biopolymers
US4836204A (en) 1987-07-06 1989-06-06 Landymore Roderick W Method for effecting closure of a perforation in the septum of the heart
US4840623A (en) 1988-02-01 1989-06-20 Fbk International Corporation Medical catheter with splined internal wall
IT1216042B (en) * 1988-03-09 1990-02-22 Carlo Rebuffat AUTOMATIC TOOL FOR TOBACCO BAG SUTURES FOR SURGICAL USE.
US4956178A (en) 1988-07-11 1990-09-11 Purdue Research Foundation Tissue graft composition
US4902508A (en) * 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
US4917089A (en) 1988-08-29 1990-04-17 Sideris Eleftherios B Buttoned device for the transvenous occlusion of intracardiac defects
FR2641692A1 (en) * 1989-01-17 1990-07-20 Nippon Zeon Co Plug for closing an opening for a medical application, and device for the closure plug making use thereof
US5245080A (en) 1989-02-20 1993-09-14 Jouveinal Sa (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-N-propylamine, process for preparing it and its therapeutical use
US5620461A (en) * 1989-05-29 1997-04-15 Muijs Van De Moer; Wouter M. Sealing device
US5149327A (en) 1989-09-05 1992-09-22 Terumo Kabushiki Kaisha Medical valve, catheter with valve, and catheter assembly
US5226879A (en) 1990-03-01 1993-07-13 William D. Ensminger Implantable access device
ATE107150T1 (en) 1990-04-02 1994-07-15 Kanji Inoue DEVICE FOR CLOSING A SHUTTLE OPENING BY A NON-OPERATIONAL METHOD.
US5078736A (en) * 1990-05-04 1992-01-07 Interventional Thermodynamics, Inc. Method and apparatus for maintaining patency in the body passages
US5021059A (en) 1990-05-07 1991-06-04 Kensey Nash Corporation Plug device with pulley for sealing punctures in tissue and methods of use
US5037433A (en) 1990-05-17 1991-08-06 Wilk Peter J Endoscopic suturing device and related method and suture
US20020032459A1 (en) * 1990-06-20 2002-03-14 Danforth Biomedical, Inc. Radially-expandable tubular elements for use in the construction of medical devices
US5041129A (en) 1990-07-02 1991-08-20 Acufex Microsurgical, Inc. Slotted suture anchor and method of anchoring a suture
EP1484077B1 (en) * 1990-10-09 2009-06-17 Medtronic, Inc. Surgical device for manipulating tissue
JPH04170966A (en) 1990-11-01 1992-06-18 Nippon Sherwood Kk Valvular body for catheter introducer blood stop valve
US5108420A (en) * 1991-02-01 1992-04-28 Temple University Aperture occlusion device
US5257637A (en) 1991-03-22 1993-11-02 El Gazayerli Mohamed M Method for suture knot placement and tying
EP0541063B1 (en) 1991-11-05 1998-09-02 The Children's Medical Center Corporation Improved occluder for repair of cardiac and vascular defects
US5282827A (en) * 1991-11-08 1994-02-01 Kensey Nash Corporation Hemostatic puncture closure system and method of use
US5222974A (en) 1991-11-08 1993-06-29 Kensey Nash Corporation Hemostatic puncture closure system and method of use
EP0876793B1 (en) 1992-01-21 2007-12-26 Regents Of The University Of Minnesota Septal Defect Closure Device
US5486193A (en) * 1992-01-22 1996-01-23 C. R. Bard, Inc. System for the percutaneous transluminal front-end loading delivery of a prosthetic occluder
US5316262A (en) 1992-01-31 1994-05-31 Suprex Corporation Fluid restrictor apparatus and method for making the same
US5167363A (en) 1992-02-10 1992-12-01 Adkinson Steven S Collapsible storage pen
US5411481A (en) 1992-04-08 1995-05-02 American Cyanamid Co. Surgical purse string suturing instrument and method
US5236440A (en) 1992-04-14 1993-08-17 American Cyanamid Company Surgical fastener
US5540712A (en) 1992-05-01 1996-07-30 Nitinol Medical Technologies, Inc. Stent and method and apparatus for forming and delivering the same
US5354308A (en) 1992-05-01 1994-10-11 Beth Israel Hospital Association Metal wire stent
DE4215449C1 (en) 1992-05-11 1993-09-02 Ethicon Gmbh & Co Kg, 2000 Norderstedt, De
US5312341A (en) 1992-08-14 1994-05-17 Wayne State University Retaining apparatus and procedure for transseptal catheterization
US5304184A (en) * 1992-10-19 1994-04-19 Indiana University Foundation Apparatus and method for positive closure of an internal tissue membrane opening
US5275826A (en) * 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US5417699A (en) 1992-12-10 1995-05-23 Perclose Incorporated Device and method for the percutaneous suturing of a vascular puncture site
US5284488A (en) * 1992-12-23 1994-02-08 Sideris Eleftherios B Adjustable devices for the occlusion of cardiac defects
US6346074B1 (en) * 1993-02-22 2002-02-12 Heartport, Inc. Devices for less invasive intracardiac interventions
US5797960A (en) 1993-02-22 1998-08-25 Stevens; John H. Method and apparatus for thoracoscopic intracardiac procedures
US5312435A (en) 1993-05-17 1994-05-17 Kensey Nash Corporation Fail predictable, reinforced anchor for hemostatic puncture closure
US5350363A (en) 1993-06-14 1994-09-27 Cordis Corporation Enhanced sheath valve
US5480424A (en) * 1993-11-01 1996-01-02 Cox; James L. Heart valve replacement using flexible tubes
JP3185906B2 (en) * 1993-11-26 2001-07-11 ニプロ株式会社 Prosthesis for atrial septal defect
US6334872B1 (en) * 1994-02-18 2002-01-01 Organogenesis Inc. Method for treating diseased or damaged organs
EP0793457B2 (en) 1994-04-06 2006-04-12 WILLIAM COOK EUROPE ApS A medical article for implantation into the vascular system of a patient
US5853420A (en) 1994-04-21 1998-12-29 B. Braun Celsa Assembly comprising a blood filter for temporary or definitive use and device for implanting it, corresponding filter and method of implanting such a filter
CA2188563C (en) 1994-04-29 2005-08-02 Andrew W. Buirge Stent with collagen
US6475232B1 (en) * 1996-12-10 2002-11-05 Purdue Research Foundation Stent with reduced thrombogenicity
US5601571A (en) * 1994-05-17 1997-02-11 Moss; Gerald Surgical fastener implantation device
US5453095A (en) 1994-06-07 1995-09-26 Cordis Corporation One piece self-aligning, self-lubricating catheter valve
US5725552A (en) * 1994-07-08 1998-03-10 Aga Medical Corporation Percutaneous catheter directed intravascular occlusion devices
US5433727A (en) 1994-08-16 1995-07-18 Sideris; Eleftherios B. Centering buttoned device for the occlusion of large defects for occluding
DE9413645U1 (en) 1994-08-24 1994-10-27 Schneidt Bernhard Ing Grad Device for closing a duct, in particular the ductus arteriosus
US5577299A (en) 1994-08-26 1996-11-26 Thompson; Carl W. Quick-release mechanical knot apparatus
US5618311A (en) * 1994-09-28 1997-04-08 Gryskiewicz; Joseph M. Surgical subcuticular fastener system
US5879366A (en) 1996-12-20 1999-03-09 W.L. Gore & Associates, Inc. Self-expanding defect closure device and method of making and using
US6171329B1 (en) * 1994-12-19 2001-01-09 Gore Enterprise Holdings, Inc. Self-expanding defect closure device and method of making and using
US5702421A (en) 1995-01-11 1997-12-30 Schneidt; Bernhard Closure device for closing a vascular opening, such as patent ductus arteriosus
US5480353A (en) * 1995-02-02 1996-01-02 Garza, Jr.; Ponciano Shaker crank for a harvester
US5634936A (en) 1995-02-06 1997-06-03 Scimed Life Systems, Inc. Device for closing a septal defect
US5649959A (en) 1995-02-10 1997-07-22 Sherwood Medical Company Assembly for sealing a puncture in a vessel
US5711969A (en) 1995-04-07 1998-01-27 Purdue Research Foundation Large area submucosal tissue graft constructs
US5733337A (en) * 1995-04-07 1998-03-31 Organogenesis, Inc. Tissue repair fabric
US6322548B1 (en) 1995-05-10 2001-11-27 Eclipse Surgical Technologies Delivery catheter system for heart chamber
US6132438A (en) * 1995-06-07 2000-10-17 Ep Technologies, Inc. Devices for installing stasis reducing means in body tissue
WO1997013463A1 (en) * 1995-10-13 1997-04-17 Transvascular, Inc. Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures
DE69612507T2 (en) * 1995-10-30 2001-08-09 Childrens Medical Center SELF-CENTERING, SHIELD-LIKE DEVICE FOR CLOSING A SEPTAL DEFECT
US5717259A (en) * 1996-01-11 1998-02-10 Schexnayder; J. Rodney Electromagnetic machine
DE19604817C2 (en) * 1996-02-09 2003-06-12 Pfm Prod Fuer Die Med Ag Device for closing defect openings in the human or animal body
CA2197614C (en) 1996-02-20 2002-07-02 Charles S. Taylor Surgical instruments and procedures for stabilizing the beating heart during coronary artery bypass graft surgery
US5853422A (en) * 1996-03-22 1998-12-29 Scimed Life Systems, Inc. Apparatus and method for closing a septal defect
US5755791A (en) 1996-04-05 1998-05-26 Purdue Research Foundation Perforated submucosal tissue graft constructs
AR001590A1 (en) * 1996-04-10 1997-11-26 Jorge Alberto Baccaro Abnormal vascular communications occluder device and applicator cartridge of said device
AU3186897A (en) 1996-05-08 1997-11-26 Salviac Limited An occluder device
US6488706B1 (en) 1996-05-08 2002-12-03 Carag Ag Device for plugging an opening such as in a wall of a hollow or tubular organ
US6143037A (en) 1996-06-12 2000-11-07 The Regents Of The University Of Michigan Compositions and methods for coating medical devices
US5893856A (en) * 1996-06-12 1999-04-13 Mitek Surgical Products, Inc. Apparatus and method for binding a first layer of material to a second layer of material
US5690674A (en) 1996-07-02 1997-11-25 Cordis Corporation Wound closure with plug
US5800516A (en) 1996-08-08 1998-09-01 Cordis Corporation Deployable and retrievable shape memory stent/tube and method
US6482224B1 (en) 1996-08-22 2002-11-19 The Trustees Of Columbia University In The City Of New York Endovascular flexible stapling device
US5776183A (en) 1996-08-23 1998-07-07 Kanesaka; Nozomu Expandable stent
US5741297A (en) * 1996-08-28 1998-04-21 Simon; Morris Daisy occluder and method for septal defect repair
US5810884A (en) 1996-09-09 1998-09-22 Beth Israel Deaconess Medical Center Apparatus and method for closing a vascular perforation after percutaneous puncture of a blood vessel in a living subject
US5861003A (en) * 1996-10-23 1999-01-19 The Cleveland Clinic Foundation Apparatus and method for occluding a defect or aperture within body surface
US5944691A (en) 1996-11-04 1999-08-31 Cordis Corporation Catheter having an expandable shaft
EP0936930B1 (en) 1996-11-05 2004-07-28 Purdue Research Foundation Myocardial graft constructs
US6315791B1 (en) 1996-12-03 2001-11-13 Atrium Medical Corporation Self-expanding prothesis
AU728848B2 (en) * 1996-12-10 2001-01-18 Purdue Research Foundation Tubular submucosal graft constructs
CA2272097C (en) 1996-12-10 2007-02-20 Purdue Research Foundation Artificial vascular valves
US5776162A (en) 1997-01-03 1998-07-07 Nitinol Medical Technologies, Inc. Vessel implantable shape memory appliance with superelastic hinged joint
JP3134288B2 (en) 1997-01-30 2001-02-13 株式会社ニッショー Endocardial suture surgery tool
JP3134287B2 (en) 1997-01-30 2001-02-13 株式会社ニッショー Catheter assembly for endocardial suture surgery
US5993844A (en) 1997-05-08 1999-11-30 Organogenesis, Inc. Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix
DK0981381T3 (en) 1997-05-12 2007-06-04 Metabolix Inc Polyhydroxyalkanoates ten applications in vivo
US6867248B1 (en) * 1997-05-12 2005-03-15 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
US6610764B1 (en) 1997-05-12 2003-08-26 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
US6071292A (en) 1997-06-28 2000-06-06 Transvascular, Inc. Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures
US6030007A (en) * 1997-07-07 2000-02-29 Hughes Electronics Corporation Continually adjustable nonreturn knot
US5928260A (en) * 1997-07-10 1999-07-27 Scimed Life Systems, Inc. Removable occlusion system for aneurysm neck
AU740068B2 (en) 1997-07-22 2001-10-25 Metabolix, Inc. Polyhydroxyalkanoate molding compositions
US6828357B1 (en) 1997-07-31 2004-12-07 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
US6174330B1 (en) * 1997-08-01 2001-01-16 Schneider (Usa) Inc Bioabsorbable marker having radiopaque constituents
US6077880A (en) 1997-08-08 2000-06-20 Cordis Corporation Highly radiopaque polyolefins and method for making the same
US6174322B1 (en) * 1997-08-08 2001-01-16 Cardia, Inc. Occlusion device for the closure of a physical anomaly such as a vascular aperture or an aperture in a septum
DE69834199T2 (en) * 1997-09-19 2006-12-14 Metabolix, Inc., Cambridge BIOLOGICAL SYSTEMS FOR THE PREPARATION OF POLYHYDROXYALKANOATE POLYMERS CONTAINING 4-HYDROXYLIC ACID
US5902319A (en) 1997-09-25 1999-05-11 Daley; Robert J. Bioabsorbable staples
US6042606A (en) 1997-09-29 2000-03-28 Cook Incorporated Radially expandable non-axially contracting surgical stent
US6106913A (en) 1997-10-10 2000-08-22 Quantum Group, Inc Fibrous structures containing nanofibrils and other textile fibers
US5989268A (en) 1997-10-28 1999-11-23 Boston Scientific Corporation Endoscopic hemostatic clipping device
US5976174A (en) 1997-12-15 1999-11-02 Ruiz; Carlos E. Medical hole closure device and methods of use
US5944738A (en) 1998-02-06 1999-08-31 Aga Medical Corporation Percutaneous catheter directed constricting occlusion device
JP3799810B2 (en) * 1998-03-30 2006-07-19 ニプロ株式会社 Transcatheter surgery closure plug and catheter assembly
US5993475A (en) 1998-04-22 1999-11-30 Bristol-Myers Squibb Co. Tissue repair device
US6113609A (en) 1998-05-26 2000-09-05 Scimed Life Systems, Inc. Implantable tissue fastener and system for treating gastroesophageal reflux disease
US7452371B2 (en) 1999-06-02 2008-11-18 Cook Incorporated Implantable vascular device
US6265333B1 (en) 1998-06-02 2001-07-24 Board Of Regents, University Of Nebraska-Lincoln Delamination resistant composites prepared by small diameter fiber reinforcement at ply interfaces
WO1999065409A1 (en) * 1998-06-10 1999-12-23 Advanced Bypass Technologies, Inc. Sutureless anastomosis systems
US6328822B1 (en) * 1998-06-26 2001-12-11 Kiyohito Ishida Functionally graded alloy, use thereof and method for producing same
US6165183A (en) 1998-07-15 2000-12-26 St. Jude Medical, Inc. Mitral and tricuspid valve repair
US5919200A (en) 1998-10-09 1999-07-06 Hearten Medical, Inc. Balloon catheter for abrading a patent foramen ovale and method of using the balloon catheter
US6183496B1 (en) 1998-11-02 2001-02-06 Datascope Investment Corp. Collapsible hemostatic plug
US7044134B2 (en) 1999-11-08 2006-05-16 Ev3 Sunnyvale, Inc Method of implanting a device in the left atrial appendage
US6152144A (en) 1998-11-06 2000-11-28 Appriva Medical, Inc. Method and device for left atrial appendage occlusion
US7713282B2 (en) * 1998-11-06 2010-05-11 Atritech, Inc. Detachable atrial appendage occlusion balloon
JP3906475B2 (en) 1998-12-22 2007-04-18 ニプロ株式会社 Transcatheter surgery closure plug and catheter assembly
US6371904B1 (en) * 1998-12-24 2002-04-16 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US6356782B1 (en) * 1998-12-24 2002-03-12 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US6217590B1 (en) * 1999-01-22 2001-04-17 Scion International, Inc. Surgical instrument for applying multiple staples and cutting blood vessels and organic structures and method therefor
US6228097B1 (en) 1999-01-22 2001-05-08 Scion International, Inc. Surgical instrument for clipping and cutting blood vessels and organic structures
EP1159015A1 (en) * 1999-03-04 2001-12-05 Tepha, Inc. Bioabsorbable, biocompatible polymers for tissue engineering
DK1163019T3 (en) * 1999-03-25 2008-03-03 Metabolix Inc Medical devices and applications of polyhydroxyalkanoate polymers
DE69927474T2 (en) * 1999-03-29 2006-07-06 William Cook Europe A/S A guidewire
US6277138B1 (en) * 1999-08-17 2001-08-21 Scion Cardio-Vascular, Inc. Filter for embolic material mounted on expandable frame
US6277139B1 (en) 1999-04-01 2001-08-21 Scion Cardio-Vascular, Inc. Vascular protection and embolic material retriever
US6379342B1 (en) * 1999-04-02 2002-04-30 Scion International, Inc. Ampoule for dispensing medication and method of use
JP2000300571A (en) 1999-04-19 2000-10-31 Nissho Corp Closure plug for transcatheter operation
US6206907B1 (en) * 1999-05-07 2001-03-27 Cardia, Inc. Occlusion device with stranded wire support arms
US6379368B1 (en) * 1999-05-13 2002-04-30 Cardia, Inc. Occlusion device with non-thrombogenic properties
US6712836B1 (en) * 1999-05-13 2004-03-30 St. Jude Medical Atg, Inc. Apparatus and methods for closing septal defects and occluding blood flow
US6488689B1 (en) 1999-05-20 2002-12-03 Aaron V. Kaplan Methods and apparatus for transpericardial left atrial appendage closure
US6426145B1 (en) 1999-05-20 2002-07-30 Scimed Life Systems, Inc. Radiopaque compositions for visualization of medical devices
US6165204A (en) 1999-06-11 2000-12-26 Scion International, Inc. Shaped suture clip, appliance and method therefor
US6494888B1 (en) 1999-06-22 2002-12-17 Ndo Surgical, Inc. Tissue reconfiguration
US6306424B1 (en) 1999-06-30 2001-10-23 Ethicon, Inc. Foam composite for the repair or regeneration of tissue
US6245080B1 (en) 1999-07-13 2001-06-12 Scion Cardio-Vascular, Inc. Suture with toggle and delivery system
US6206895B1 (en) 1999-07-13 2001-03-27 Scion Cardio-Vascular, Inc. Suture with toggle and delivery system
US6398796B2 (en) 1999-07-13 2002-06-04 Scion Cardio-Vascular, Inc. Suture with toggle and delivery system
US7892246B2 (en) 1999-07-28 2011-02-22 Bioconnect Systems, Inc. Devices and methods for interconnecting conduits and closing openings in tissue
US6328689B1 (en) 2000-03-23 2001-12-11 Spiration, Inc., Lung constriction apparatus and method
US6231561B1 (en) 1999-09-20 2001-05-15 Appriva Medical, Inc. Method and apparatus for closing a body lumen
US6551303B1 (en) 1999-10-27 2003-04-22 Atritech, Inc. Barrier device for ostium of left atrial appendage
US6387104B1 (en) 1999-11-12 2002-05-14 Scimed Life Systems, Inc. Method and apparatus for endoscopic repair of the lower esophageal sphincter
US6371971B1 (en) 1999-11-15 2002-04-16 Scimed Life Systems, Inc. Guidewire filter and methods of use
US7335426B2 (en) * 1999-11-19 2008-02-26 Advanced Bio Prosthetic Surfaces, Ltd. High strength vacuum deposited nitinol alloy films and method of making same
US20010041914A1 (en) 1999-11-22 2001-11-15 Frazier Andrew G.C. Tissue patch deployment catheter
US6790218B2 (en) * 1999-12-23 2004-09-14 Swaminathan Jayaraman Occlusive coil manufacture and delivery
DE10000137A1 (en) 2000-01-04 2001-07-12 Pfm Prod Fuer Die Med Ag Implantate for closing defect apertures in human or animal bodies, bearing structure of which can be reversed from secondary to primary form by elastic force
US6780197B2 (en) * 2000-01-05 2004-08-24 Integrated Vascular Systems, Inc. Apparatus and methods for delivering a vascular closure device to a body lumen
US20010034567A1 (en) 2000-01-20 2001-10-25 Allen Marc L. Remote management of retail petroleum equipment
FR2804567B1 (en) 2000-01-31 2002-04-12 St Microelectronics Sa VIDEO PREAMPLIFIER
US6227139B1 (en) 2000-03-16 2001-05-08 The United States Of America As Represented By The Secretary Of The Navy Control tab assisted lift reducing system for underwater hydrofoil surface
US7056294B2 (en) 2000-04-13 2006-06-06 Ev3 Sunnyvale, Inc Method and apparatus for accessing the left atrial appendage
JP3844661B2 (en) * 2000-04-19 2006-11-15 ラディ・メディカル・システムズ・アクチェボラーグ Intra-arterial embolus
US6214029B1 (en) * 2000-04-26 2001-04-10 Microvena Corporation Septal defect occluder
US6551344B2 (en) 2000-04-26 2003-04-22 Ev3 Inc. Septal defect occluder
US6352552B1 (en) * 2000-05-02 2002-03-05 Scion Cardio-Vascular, Inc. Stent
US6599448B1 (en) 2000-05-10 2003-07-29 Hydromer, Inc. Radio-opaque polymeric compositions
US6334864B1 (en) 2000-05-17 2002-01-01 Aga Medical Corp. Alignment member for delivering a non-symmetric device with a predefined orientation
KR20040014389A (en) 2000-07-21 2004-02-14 메타볼릭스 인코포레이티드 Production of polyhydroxyalkanoates from polyols
US6440152B1 (en) 2000-07-28 2002-08-27 Microvena Corporation Defect occluder release assembly and method
JP2004506469A (en) * 2000-08-18 2004-03-04 アトリテック, インコーポレイテッド Expandable implantable device for filtering blood flow from the atrial appendage
US6867249B2 (en) * 2000-08-18 2005-03-15 Kin Man Amazon Lee Lightweight and porous construction materials containing rubber
US20020029048A1 (en) * 2000-09-01 2002-03-07 Arnold Miller Endovascular fastener and grafting apparatus and method
US6364853B1 (en) * 2000-09-11 2002-04-02 Scion International, Inc. Irrigation and suction valve and method therefor
JP3722682B2 (en) * 2000-09-21 2005-11-30 富士通株式会社 Transmission device that automatically changes the type of transmission data within a specific band
JP2004508879A (en) * 2000-09-21 2004-03-25 アトリテック, インコーポレイテッド Apparatus for implanting a device in the atrial appendage
US6699278B2 (en) 2000-09-22 2004-03-02 Cordis Corporation Stent with optimal strength and radiopacity characteristics
NZ525519A (en) 2000-09-25 2005-01-28 Cohesion Tech Inc Resorbable anastomosis stents for insertion into an opening in a lumen of a vessel or tissue of a patient
US6666861B1 (en) 2000-10-05 2003-12-23 James R. Grabek Atrial appendage remodeling device and method
US6375625B1 (en) * 2000-10-18 2002-04-23 Scion Valley, Inc. In-line specimen trap and method therefor
US6629901B2 (en) 2000-11-09 2003-10-07 Ben Huang Composite grip for golf clubs
US6508828B1 (en) * 2000-11-03 2003-01-21 Radi Medical Systems Ab Sealing device and wound closure device
US6746404B2 (en) 2000-12-18 2004-06-08 Biosense, Inc. Method for anchoring a medical device between tissue
US20020128680A1 (en) 2001-01-25 2002-09-12 Pavlovic Jennifer L. Distal protection device with electrospun polymer fiber matrix
US6550480B2 (en) 2001-01-31 2003-04-22 Numed/Tech Llc Lumen occluders made from thermodynamic materials
US20020107531A1 (en) 2001-02-06 2002-08-08 Schreck Stefan G. Method and system for tissue repair using dual catheters
US6623518B2 (en) 2001-02-26 2003-09-23 Ev3 Peripheral, Inc. Implant delivery system with interlock
JP2005508201A (en) * 2001-03-08 2005-03-31 アトリテック, インコーポレイテッド Atrial filter implant
US6726696B1 (en) 2001-04-24 2004-04-27 Advanced Catheter Engineering, Inc. Patches and collars for medical applications and methods of use
WO2002089863A1 (en) * 2001-05-04 2002-11-14 Concentric Medical Bioactive polymer vaso-occlusive device
US6921410B2 (en) 2001-05-29 2005-07-26 Scimed Life Systems, Inc. Injection molded vaso-occlusive elements
US6537300B2 (en) 2001-05-30 2003-03-25 Scimed Life Systems, Inc. Implantable obstruction device for septal defects
US7338514B2 (en) 2001-06-01 2008-03-04 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods and tools, and related methods of use
EP1392394A4 (en) 2001-06-04 2005-05-18 Albert Einstein Healthcare Network Cardiac stimulating apparatus having a blood clot filter and atrial pacer
US6585755B2 (en) 2001-06-29 2003-07-01 Advanced Cardiovascular Polymeric stent suitable for imaging by MRI and fluoroscopy
WO2003007825A1 (en) * 2001-07-19 2003-01-30 Atritech, Inc. Individually customized device for covering the ostium of left atrial appendage
US7288105B2 (en) * 2001-08-01 2007-10-30 Ev3 Endovascular, Inc. Tissue opening occluder
US6776784B2 (en) * 2001-09-06 2004-08-17 Core Medical, Inc. Clip apparatus for closing septal defects and methods of use
US6702835B2 (en) * 2001-09-07 2004-03-09 Core Medical, Inc. Needle apparatus for closing septal defects and methods for using such apparatus
US6596013B2 (en) * 2001-09-20 2003-07-22 Scimed Life Systems, Inc. Method and apparatus for treating septal defects
US7318833B2 (en) 2001-12-19 2008-01-15 Nmt Medical, Inc. PFO closure device with flexible thrombogenic joint and improved dislodgement resistance
US20030139819A1 (en) 2002-01-18 2003-07-24 Beer Nicholas De Method and apparatus for closing septal defects
US7431729B2 (en) * 2002-06-05 2008-10-07 Nmt Medical, Inc. Patent foramen ovale (PFO) closure device with radial and circumferential support
US20040093017A1 (en) 2002-11-06 2004-05-13 Nmt Medical, Inc. Medical devices utilizing modified shape memory alloy
AU2003294682A1 (en) 2002-12-09 2004-06-30 Nmt Medical, Inc. Septal closure devices
US7780700B2 (en) * 2003-02-04 2010-08-24 ev3 Endovascular, Inc Patent foramen ovale closure system
US20040234567A1 (en) 2003-05-22 2004-11-25 Dawson Richard A. Collapsible shield for smoking animal lure
CA2531833C (en) * 2003-07-08 2009-10-20 Tepha, Inc. Poly-4-hydroxybutyrate matrices for sustained drug delivery
US8480706B2 (en) * 2003-07-14 2013-07-09 W.L. Gore & Associates, Inc. Tubular patent foramen ovale (PFO) closure device with catch system
ES2428967T3 (en) * 2003-07-14 2013-11-12 W.L. Gore & Associates, Inc. Oval foramen tubular permeable closure device (FOP) with retention system
US20050113868A1 (en) 2003-11-20 2005-05-26 Devellian Carol A. Device, with electrospun fabric, for a percutaneous transluminal procedure, and methods thereof
DE602004007555T2 (en) 2004-02-04 2008-03-13 Carag Ag IMPLANT FOR THE OCCLUSION OF A BODY CHANNEL
CA2558247A1 (en) 2004-03-03 2005-10-06 Nmt Medical, Inc. Delivery/recovery system for septal occluder
US7704268B2 (en) 2004-05-07 2010-04-27 Nmt Medical, Inc. Closure device with hinges
JP2007535997A (en) 2004-05-07 2007-12-13 エヌエムティー メディカル, インコーポレイティッド Capturing mechanism of tubular septal occluder
WO2006036837A2 (en) 2004-09-24 2006-04-06 Nmt Medical, Inc. Occluder device double securement system for delivery/recovery of such occluder device
EP1868507A1 (en) 2005-03-18 2007-12-26 NMT Medical, Inc. Catch member for pfo occluder
WO2007073566A1 (en) 2005-12-22 2007-06-28 Nmt Medical, Inc. Catch members for occluder devices

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5451235A (en) * 1991-11-05 1995-09-19 C.R. Bard, Inc. Occluder and method for repair of cardiac and vascular defects
US5733294A (en) * 1996-02-28 1998-03-31 B. Braun Medical, Inc. Self expanding cardiovascular occlusion device, method of using and method of making the same
US20030191495A1 (en) * 2001-12-19 2003-10-09 Nmt Medical, Inc. Septal occluder and associated methods
US20030225421A1 (en) * 2002-03-25 2003-12-04 Nmt Medical, Inc. Patent foramen ovale (PFO) closure clips

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11607207B2 (en) * 2016-05-16 2023-03-21 Boston Scientific Scimed, Inc. Devices and methods for reducing a dimension of openings in tissue
US10426473B2 (en) * 2017-10-19 2019-10-01 Abbott Cardiovascular Systems Inc. System and method for plicating a heart valve

Also Published As

Publication number Publication date
US8361110B2 (en) 2013-01-29
US20050267525A1 (en) 2005-12-01

Similar Documents

Publication Publication Date Title
US8361110B2 (en) Heart-shaped PFO closure device
US11375988B2 (en) Patent foramen ovale (PFO) closure device with linearly elongating petals
US9326759B2 (en) Tubular patent foramen ovale (PFO) closure device with catch system
US9149263B2 (en) Tubular patent foramen ovale (PFO) closure device with catch system
US8828049B2 (en) Split ends closure device and methods of use
JP4597990B2 (en) PFO closure device with flexible thrombogenic joint and improved detachability
US8753362B2 (en) Double spiral patent foramen ovale closure clamp
US7867250B2 (en) Septal occluder and associated methods
US9554806B2 (en) Occlusive devices
US9017373B2 (en) Septal closure devices
US20080077180A1 (en) Scaffold for tubular septal occluder device and techniques for attachment
US20090318956A1 (en) Wire-Like And Other Devices For Treating Septal Defects And Systems And Methods For Delivering The Same

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION